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Objective:  To study the regularity of migration and dis-
tribution of bone marrow stromal cells (BMSCs) in injured
spinal cord with intradural space transplantation.
Methods:  Forty Wistar rats were randomly assigned
into 4 groups. The spinal cord injury model was prepared
according to the modified Allen method. BMSCs were la-
beled by CM-Dil. And 5.0×106 cells were transplanted by
different channels including intraventricular injection (Group
A),injured spinal cord intrathecally injection (Group B), re-
mote intrathecally injection at the L3-L4 level (Group C), and
intravenous injection (Group D). Spinal cord was dissected
at 24 hours, 1, 2, 3 and 4 weeks after transplantation. Sec-
tions of 4 µm were cut on a cryostat and observed under
fluorescence microscopy.
Results:  No fluorescence was observed 24 hours after
transplantation in spinal cord injury parenchyma except
Group B. One week later, BMSCs in Groups A and C began
to migrate to the injured parenchyma; 2-4 weeks later, BMSCs
penetrated into the injured parenchyma except Group D.
The number of BMSCs decreased at 3-4 weeks after
transplantation. The number of cells in Group B decreased
faster than that of Groups A and C.
Conclusions:  BMSCs transplanted through intraven-
tricular injection, injured spinal cord intrathecally injection
and remote intrathecal injection could migrate to the injured
parenchyma of spinal cord effectively. The number of
BMSCs migrated into injured spinal cord parenchyma is
rare by intravenous injection.
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Cell transplantation has shown great promisein the treatment of spinal cord injury (SCI).There are several candidates that have shown
therapeutic potential, such as embryonic stem cells,
olfactory ensheathing glial cells, Schwann cells and
bone marrow stromal cells (BMSCs). In order to take
effect, these cells have to be injected into injured spi-
nal cord parenchyma. As we know, it is impossible to
transplant a large quantity of cells into spinal cord pa-
renchyma by routine channels. Meanwhile, injured
spinal cord tissue will release many inflammatory and
cytotoxic chemokines that are harmful to transplanted
cells. It is necessary to study the optimal approach
that can transplant cells efficaciously.
METHODS
Culture of BMSCs
BMSCs were obtained from 5 donor adult male
Wister rats (weighing 250-300 g). All the rats were sac-
rificed by overdose anesthesia. Tibias and femurs of
the rats were dissected aseptically and both ends of
the bones were cut out. Fresh bone marrow was har-
vested by inserting a 21-gauge needle connected to a
1 ml syringe into the shaft of the bone and flushing
bone marrow out with 10 ml DMEM. Bone marrow was
mechanically dissociated to obtain a homogeneous cell
suspension. The cell suspension was filtered through
a 70 µm mesh nylon strainer and placed in a 75 cm2
flask for tissue culture with 12 ml DMEM medium con-
taining 10% fetal bovine serum (FBS), 2 mol glutamine,
100 units/ml penicillin, 100 µg/ml streptomycin. The
cells were incubated at 37°C in 5% CO2 for 3 days. At
this time, non-adherent cells were removed by replac-
ing the medium. The culture medium was replaced 3
times a week. After the culture reached confluent, the
BMSCs were collected by incubation in a solution con-
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taining 0.25% trypsin and 1 ml EDTA for 5 minutes at
37°C.  After resuspended in fresh DMEM, the cells
were transferred to new flasks and grew for 3 passages.
BMSCs were suspended at 2¡Á106 cells/ml PBS,
then treated with 0.75 µg of CM-DiI (Molecular Probe
Company, USA) /106 cells for 10 minutes at 37°C fol-
lowed by 15 minutes on ice. Cells were then washed
and suspended at 1.0¡Á105 cells/µ l PBS.
Spinal cord injury model
The animal model was prepared under anesthesia
with pentobarbital sodium (50 mg/kg, ip), laminectomy
was performed at T11 level of spinal cord. A metal rod of
10 g in weight and 2.0 mm in diameter was dropped
from a height of 15 cm, guided by a hollow cylinder,
just onto the exposed spinal cord for contusion injury.
The rats were placed in a temperature and humidity
controlled chamber, manual bladder compression three
times a day for the first week and twice daily thereafter.
BMSCs transplantation
Forty adult male Wistar rats (weighing 250-300 g)
were randomly assigned to 4 groups. In Group A, a
vertical skin incision was made and 1 mm-diameter
hole was drilled in the skull at the site of 3.5 mm cau-
dal to the lambda in the midline. A needle was punc-
tured into the dura of the fourth ventricle, and 50 µ l
labeled BMSCs was injected in 1 minute. In Group B,
50 µl labeled BMSCs was directly injected intrathecally
at the site of injured spinal cord within 1 minute. In
Group C, a 1-cm skin incision was made at the level of L3-
L4; laminectomy was performed and 50 µl labeled BMSCs
was injected intrathecally in 1 minute at the same level.
In Group D, a 1-cm skin incision was made over the
groin and the femoral vein was exposed, and 50 µl la-
beled BMSCs was injected in 1 minute.
Observation under fluorescent microscope
Two rats were selected randomly in each group at
24 hours, 1, 2, 3 and 4 weeks after transplantation.
The rats were deeply anesthetized by pentobarbital.
Spinal cord was dissected aseptically and fixed in 4%
paraformaldehyde for 2 hours, transferred to 20% su-
crose solution for one night. Frozen and cut in a cry-
ostat at 4 µm thickness. Dried naturally for 30 minutes,
fixed by cold acetone (4°C) for 10 minutes and rinsed
with PBS for 3 times. The slices were observed under
fluorescence microscopy (Leica Dmirb Company,
Germany).
Statistical analysis
All the data were analyzed with SPSS 10.0 statis-
tical software and expressed as x ± s. q test (Newman-
keuls method) was used to identify the significant
difference. And P<0.01 was considered statistically
significant.
RESULTS
Migration of BMSCs in each group (Table 1)
Twenty-four hours after transplantation, no red fluo-
rescence was observed in the injured spinal cord area
in every group except Group B.
One week after transplantation, no cells were
present within the injured spinal segments in Group D.
Some BMSCs migrated into the injured spinal seg-
ments in Groups A and C, but most of them were un-
der the spinal arachnoid mater. BMSCs migrated into
the parenchyma of the injured spinal cord which at-
tached to the spinal arachnoid mater in Group B (Figs.
1 and 2).
Two weeks after transplantation, very few cells were
present within the injured spinal cord in Group D. Con-
siderably more cells migrated to the injured spinal cord
tissues in other three groups (Fig. 3).
Three weeks after transplantation, the number of
cells within the injured spinal cord tissues decreased
in Group B and the cells had little change in other groups
(Figs. 4 and 5).
Four weeks after transplantation, the number of cells
in each group further decreased. The number of cells
in Group B was less than that in Groups A and C. All
the cells concentrated in the center of injured spinal
cord parenchyma. There were very few cells in the in-
jured spinal cord area in Group D (Fig. 6).
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DISCUSSION
Cell transplantation is at present considered to be
the most effective way to repair spinal cord injuries.
Several different kinds of cells have been used as trans-
plant for spinal cord regeneration, including Schwann
cells,1 embryonic spinal cord,2 olfactory ensheathing
cells3 and neural stem cells.4 These cells have shown
great promise in the treatment of spinal cord injury.
However, ethical problems make it impossible to use
human fetal tissue as a practical source for therapeu-
tic treatment. In this circumstance, BMSCs are attrac-
tive clinically because they can be obtained in patients
at bedside without ethical problems. BMSCs show ef-
fective treatment on the repair of injured spinal cord
and on the behavioral improvement.5,6
An unresolved problem is which cell transplanta-
tion technique can bring best therapeutic effects. Most
investigators have undertaken the technique of injecting
cells into the injured spinal cord parenchyma.7 Although
Table 1. The number of BMSCs migrated into injured spinal cord tissues in each group. (x ± s, n=10)
Groups After transplantation
            1 week                         2 weeks                     3 weeks                        4 weeks
A
B
C
D
3.14±0.56 42.52±6.27 40.78±6.57** 35.49±5.14**
51.32±6.77* 46.77±6.42 30.61±5.46 21.51±3.21
18.42±2.56 47.95±5.59 45.68±6.19** 38.24±5.46**
2.02±0.19 2.33±0.21 1.86±0.140
*P<0.01, compared with Groups A and C; **P<0.01,compared with Group B.
Fig. 1. All the pictures were taken under the same ana-
tomic field, the left one being bright field and the right one,
fluorescent field. One week after BMSCs transplantation in
Group A, a few cells migrated to the injured spinal arach-
noid mater (×100).
Fig. 2. One week after BMSCs transplantation in Group B,
some cells located under the injured spinal arachnoid
mater, and some cells migrated into the injured spinal
parenchyma (×200).
Fig. 3. Two weeks after BMSCs transplantation in Group
B, some cells migrated and concentrated within the in-
jured spinal parenchyma (×200).
Fig. 4. Three weeks after BMSCs transplantation in Group
A, cells migrated and concentrated within the injured spi-
nal grey matter (×200).
Fig. 5. Three weeks after BMSCs transplantation in Group
C, cells migrated and concentrated within the injured spi-
nal grey matter (×200).
Fig. 6. Four weeks after BMSCs transplantation in Group
B, the traumatic spinal cord cavity can be seen and the
number of BMSCs decreased (×200).
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this technique can bring transplanted cells into the in-
jured tissues directly, it is dangerous for the normal
spinal cord tissues. It is known that injured neuro-tis-
sues do not tolerate operative manipulation as well as
normal tissues because of the presence of edema,
pressure, and altered blood flow. Since the space is
limited, it is impossible to inject enough therapeutic
cells into the injured spinal cord parenchyma. Finally,
injured spinal cord tissues release many inflammatory
and cytotoxic chemokines that make the local envi-
ronment hostile to the transplanted cells. Therefore this
technique is seldom used in acute spinal cord injury.
Intravascular delivery of BMSCs is a minimally in-
vasive cell transplantation technique.  Some investiga-
tors have demonstrated cellular homing into the patho-
logical CNS tissues including injured spinal cord tis-
sues after intravenous injection.8 Khalatbary and Tiraihi9
transplanted BMSCs intravenously into the rats 1 week
after SCI and found that the migration of BMSCs in the
injured region depends on the amount of the hemor-
rhage and damage to blood vessels of the spinal cord.
Vaquero and his colleagues6 compared the effect of
systemic and local administration of BMSC in adult
Wistar rats suffering chronic paraplegia as conse-
quence of severe SCI and found that intravenous ad-
ministration of BMSC achieves some degree of func-
tional recovery when compared to controls.
Nevertheless, administration of BMSC into posttrau-
matic spinal cord cavity promotes a clear and progres-
sive functional recovery, significantly superior to the
recovery obtained by means of the intravenous
administration. But Bakshi10 compared different cell
transplantation techniques and found that very few or
no cell is present within the injured spinal segments in
rat that received BMSCs intravenously. In contrast,
considerably more cells are detected in the injured tis-
sues after both intraventricular and lumbar puncture
delivery. We also found that intra-CSF delivery could
bring more cells into injured spinal tissues than intra-
vascular delivery.
Techniques of intra-cerebrospinal fluid (CSF) deliv-
ery include intraventricular injection and intrathecal in-
jection directly or through lumbar puncture. In this
study, BMSCs delivery via CSF selectively homed to-
ward the injured spinal cord tissues. But the number
of BMSCs delivered intrathecally at the site of injured
spinal cord decreased faster than that delivered
intrathecally far away from the injured tissues. This
indicates that injured spinal cord tissues may release
inflammatory and cytotoxic chemokines that are harm-
ful to BMSCs survival. Cells delivered far away from
the injured site may avoid the hostile environment and
have a greater opportunity to survive. CSF circulates
within the central nerve system, allowing transplanted
cells to migrate and home into the injured tissues. In-
trathecal transplantation through lumbar puncture in
rat is considerably difficult, but it is a minimally inva-
sive procedure and easy to perform in humans.
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